Epstein Secrets

613.6 1130/ 57972 1111111.4 1109 133.5 1641 144.2 173.2 192 Mag» 00 14.3% 112% 144% 150% 111% EB1T Pl 10.4 151.1 1511 1473 110 Mavo& 110% 141% Ite% niw. »10 Na ba» 1S1.51 514 1012 101.2 Mr0.0..1 MI% /6.00 1/1100115 0.321 1.16 221 211 257 211 Ce» 11» 0000.61 'R

II 14 %SN EPS Hbllyn SeeNuon1 • ,i.t. entibCrxteiffii tas %ut Immun s ch hm intionffig l'emmena& Amm. t ffiul Espentlisics agace SYM 1.ni Mao, lu% Luldnics 1.94 Fqeds ut. %Vende CsOld (Au Fut MAC si.d.Taa Pif 1 ...À Cu% 4•44 Cul. ts4 Nd 190E /bal Vin Gan. LTM Nå Ter Faim. Dte.31

value for the Company's equity. Please see Exhibits F and G for further details related to our analysis utilizing the Income Approach. • PCMMM of the Market Approach. This methodology was considered as a reasonableness check in our analysis, but ultimately not relied upon due to differences between the Company an

613.6 1130/ 57972 1111111.4 1109 133.5 1641 144.2 173.2 192 Mag» 00 14.3% 112% 144% 150% 111% EB1T Pl 10.4 151.1 1511 1473 110 Mavo& 110% 141% Ite% niw. »10 Na ba» 1S1.51 514 1012 101.2 Mr0.0..1 MI% /6.00 1/1100115 0.321 1.16 221 211 257 211 Ce» 11» 0000.61 'R

II 14 %SN EPS Hbllyn SeeNuon1 • ,i.t. entibCrxteiffii tas %ut Immun s ch hm intionffig l'emmena& Amm. t ffiul Espentlisics agace SYM 1.ni Mao, lu% Luldnics 1.94 Fqeds ut. %Vende CsOld (Au Fut MAC si.d.Taa Pif 1 ...À Cu% 4•44 Cul. ts4 Nd 190E /bal Vin Gan. LTM Nå Ter Faim. Dte.31

value for the Company's equity. Please see Exhibits F and G for further details related to our analysis utilizing the Income Approach. • PCMMM of the Market Approach. This methodology was considered as a reasonableness check in our analysis, but ultimately not relied upon due to differences between the Company an

613.6 1130/ 57972 1111111.4 1109 133.5 1641 144.2 173.2 192 Mag» 00 14.3% 112% 144% 150% 111% EB1T Pl 10.4 151.1 1511 1473 110 Mavo& 110% 141% Ite% niw. »10 Na ba» 1S1.51 514 1012 101.2 Mr0.0..1 MI% /6.00 1/1100115 0.321 1.16 221 211 257 211 Ce» 11» 0000.61 'R

II 14 %SN EPS Hbllyn SeeNuon1 • ,i.t. entibCrxteiffii tas %ut Immun s ch hm intionffig l'emmena& Amm. t ffiul Espentlisics agace SYM 1.ni Mao, lu% Luldnics 1.94 Fqeds ut. %Vende CsOld (Au Fut MAC si.d.Taa Pif 1 ...À Cu% 4•44 Cul. ts4 Nd 190E /bal Vin Gan. LTM Nå Ter Faim. Dte.31

value for the Company's equity. Please see Exhibits F and G for further details related to our analysis utilizing the Income Approach. • PCMMM of the Market Approach. This methodology was considered as a reasonableness check in our analysis, but ultimately not relied upon due to differences between the Company an